nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—Distention—Octreotide—thymus cancer	0.0833	0.0833	CcSEcCtD
Fondaparinux sodium—Clotting—Octreotide—thymus cancer	0.055	0.055	CcSEcCtD
Fondaparinux sodium—Abdominal bloating—Octreotide—thymus cancer	0.0412	0.0412	CcSEcCtD
Fondaparinux sodium—Local reaction—Octreotide—thymus cancer	0.0355	0.0355	CcSEcCtD
Fondaparinux sodium—Haematoma—Octreotide—thymus cancer	0.0312	0.0312	CcSEcCtD
Fondaparinux sodium—Intestinal obstruction—Octreotide—thymus cancer	0.0288	0.0288	CcSEcCtD
Fondaparinux sodium—Coagulopathy—Octreotide—thymus cancer	0.0252	0.0252	CcSEcCtD
Fondaparinux sodium—Tingling sensation—Octreotide—thymus cancer	0.0244	0.0244	CcSEcCtD
Fondaparinux sodium—Contusion—Octreotide—thymus cancer	0.0225	0.0225	CcSEcCtD
Fondaparinux sodium—Extravasation—Octreotide—thymus cancer	0.0225	0.0225	CcSEcCtD
Fondaparinux sodium—Cellulitis—Octreotide—thymus cancer	0.0216	0.0216	CcSEcCtD
Fondaparinux sodium—Hyperbilirubinaemia—Octreotide—thymus cancer	0.0216	0.0216	CcSEcCtD
Fondaparinux sodium—Drug interaction—Octreotide—thymus cancer	0.0212	0.0212	CcSEcCtD
Fondaparinux sodium—Phlebitis—Octreotide—thymus cancer	0.0165	0.0165	CcSEcCtD
Fondaparinux sodium—Cardiac failure congestive—Octreotide—thymus cancer	0.0157	0.0157	CcSEcCtD
Fondaparinux sodium—Hot flush—Octreotide—thymus cancer	0.0152	0.0152	CcSEcCtD
Fondaparinux sodium—Menopausal symptoms—Octreotide—thymus cancer	0.0151	0.0151	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Octreotide—thymus cancer	0.0143	0.0143	CcSEcCtD
Fondaparinux sodium—Irritability—Octreotide—thymus cancer	0.0136	0.0136	CcSEcCtD
Fondaparinux sodium—Dehydration—Octreotide—thymus cancer	0.0133	0.0133	CcSEcCtD
Fondaparinux sodium—Gastritis—Octreotide—thymus cancer	0.0126	0.0126	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Octreotide—thymus cancer	0.0124	0.0124	CcSEcCtD
Fondaparinux sodium—Bronchospasm—Octreotide—thymus cancer	0.0121	0.0121	CcSEcCtD
Fondaparinux sodium—Sweating increased—Octreotide—thymus cancer	0.012	0.012	CcSEcCtD
Fondaparinux sodium—Bronchitis—Octreotide—thymus cancer	0.0118	0.0118	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Octreotide—thymus cancer	0.0107	0.0107	CcSEcCtD
Fondaparinux sodium—Haematuria—Octreotide—thymus cancer	0.0105	0.0105	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Octreotide—thymus cancer	0.0104	0.0104	CcSEcCtD
Fondaparinux sodium—Epistaxis—Octreotide—thymus cancer	0.0104	0.0104	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Octreotide—thymus cancer	0.00981	0.00981	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Octreotide—thymus cancer	0.00971	0.00971	CcSEcCtD
Fondaparinux sodium—Flushing—Octreotide—thymus cancer	0.00915	0.00915	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Octreotide—thymus cancer	0.00891	0.00891	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Octreotide—thymus cancer	0.00881	0.00881	CcSEcCtD
Fondaparinux sodium—Malnutrition—Octreotide—thymus cancer	0.00858	0.00858	CcSEcCtD
Fondaparinux sodium—Flatulence—Octreotide—thymus cancer	0.00846	0.00846	CcSEcCtD
Fondaparinux sodium—Back pain—Octreotide—thymus cancer	0.0083	0.0083	CcSEcCtD
Fondaparinux sodium—Vision blurred—Octreotide—thymus cancer	0.00809	0.00809	CcSEcCtD
Fondaparinux sodium—Anaemia—Octreotide—thymus cancer	0.00793	0.00793	CcSEcCtD
Fondaparinux sodium—Vertigo—Octreotide—thymus cancer	0.00771	0.00771	CcSEcCtD
Fondaparinux sodium—Syncope—Octreotide—thymus cancer	0.0077	0.0077	CcSEcCtD
Fondaparinux sodium—Palpitations—Octreotide—thymus cancer	0.00759	0.00759	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Octreotide—thymus cancer	0.00754	0.00754	CcSEcCtD
Fondaparinux sodium—Cough—Octreotide—thymus cancer	0.00749	0.00749	CcSEcCtD
Fondaparinux sodium—Convulsion—Octreotide—thymus cancer	0.00744	0.00744	CcSEcCtD
Fondaparinux sodium—Chest pain—Octreotide—thymus cancer	0.00731	0.00731	CcSEcCtD
Fondaparinux sodium—Anxiety—Octreotide—thymus cancer	0.00728	0.00728	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00726	0.00726	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Octreotide—thymus cancer	0.00701	0.00701	CcSEcCtD
Fondaparinux sodium—Oedema—Octreotide—thymus cancer	0.00701	0.00701	CcSEcCtD
Fondaparinux sodium—Infection—Octreotide—thymus cancer	0.00696	0.00696	CcSEcCtD
Fondaparinux sodium—Shock—Octreotide—thymus cancer	0.00689	0.00689	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Octreotide—thymus cancer	0.00687	0.00687	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Octreotide—thymus cancer	0.00686	0.00686	CcSEcCtD
Fondaparinux sodium—Tachycardia—Octreotide—thymus cancer	0.00684	0.00684	CcSEcCtD
Fondaparinux sodium—Skin disorder—Octreotide—thymus cancer	0.0068	0.0068	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Octreotide—thymus cancer	0.00677	0.00677	CcSEcCtD
Fondaparinux sodium—Anorexia—Octreotide—thymus cancer	0.00668	0.00668	CcSEcCtD
Fondaparinux sodium—Insomnia—Octreotide—thymus cancer	0.00634	0.00634	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Octreotide—thymus cancer	0.00629	0.00629	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Octreotide—thymus cancer	0.00625	0.00625	CcSEcCtD
Fondaparinux sodium—Somnolence—Octreotide—thymus cancer	0.00623	0.00623	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Octreotide—thymus cancer	0.00617	0.00617	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Octreotide—thymus cancer	0.00609	0.00609	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Octreotide—thymus cancer	0.00605	0.00605	CcSEcCtD
Fondaparinux sodium—Fatigue—Octreotide—thymus cancer	0.00604	0.00604	CcSEcCtD
Fondaparinux sodium—Constipation—Octreotide—thymus cancer	0.00599	0.00599	CcSEcCtD
Fondaparinux sodium—Pain—Octreotide—thymus cancer	0.00599	0.00599	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Octreotide—thymus cancer	0.00577	0.00577	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Octreotide—thymus cancer	0.00573	0.00573	CcSEcCtD
Fondaparinux sodium—Urticaria—Octreotide—thymus cancer	0.00557	0.00557	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Octreotide—thymus cancer	0.00554	0.00554	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Octreotide—thymus cancer	0.00554	0.00554	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Octreotide—thymus cancer	0.00516	0.00516	CcSEcCtD
Fondaparinux sodium—Asthenia—Octreotide—thymus cancer	0.00503	0.00503	CcSEcCtD
Fondaparinux sodium—Pruritus—Octreotide—thymus cancer	0.00496	0.00496	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Octreotide—thymus cancer	0.00479	0.00479	CcSEcCtD
Fondaparinux sodium—Dizziness—Octreotide—thymus cancer	0.00463	0.00463	CcSEcCtD
Fondaparinux sodium—Vomiting—Octreotide—thymus cancer	0.00445	0.00445	CcSEcCtD
Fondaparinux sodium—Rash—Octreotide—thymus cancer	0.00442	0.00442	CcSEcCtD
Fondaparinux sodium—Dermatitis—Octreotide—thymus cancer	0.00441	0.00441	CcSEcCtD
Fondaparinux sodium—Headache—Octreotide—thymus cancer	0.00439	0.00439	CcSEcCtD
Fondaparinux sodium—Nausea—Octreotide—thymus cancer	0.00416	0.00416	CcSEcCtD
